Insider Shareholders with Direct Ownership of Kura Oncology, Inc. (KURA)
This section provides a comprehensive overview of the insiders with direct ownership of Kura Oncology, Inc. (KURA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Kura Oncology, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Teresa Brophy Bair
Chief Legal Officer |
115,625 | 14,049 | 107,948 $866,822 | 7 |
Jan 28, 2025
Reduced 4.29%
|
|
Mollie Leoni
Chief Medical Officer |
46,250 | 4,963 | 88,253 $708,671 | 2 |
Jan 28, 2025
Reduced 0.61%
|
|
Thomas James Doyle
SVP, Finance & Accounting |
82,765 | 8,815 | 88,193 $708,189 | 7 |
Jan 28, 2025
Reduced 1.26%
|
|
Brian T. Powl
Chief Commercial Officer |
61,250 | 1,583 | 59,667 $479,126 | 3 |
Jan 28, 2025
Reduced 2.58%
|
|
Stephen Dale
Chief Medical Officer |
60,025 | 21,208 | 38,817 $311,700 | 5 |
Jan 30, 2024
Reduced 11.06%
|
|
Marc Grasso
CFO, CBO |
21,900 | 0 | 21,900 $175,857 | 1 |
Jan 26, 2022
Added 50.0%
|
|
Kathleen Ford
Chief Operating Officer |
43,775 | 27,535 | 21,367 $171,577 | 11 |
Jan 28, 2025
Reduced 7.84%
|
|
Francis Burrows
Chief Scientific Officer |
0 | 2,166 | 20,705 $166,261 | 1 |
Jan 28, 2025
Reduced 5.99%
|
|
Kirsten Flowers
CCO & Chief Strategy Officer |
21,900 | 1,906 | 20,605 $165,458 | 2 |
Jan 27, 2023
Reduced 8.47%
|
|
Troy Edward Wilson
President and CEO |
157,863 | 187,959 | 559 $4,488 | 10 |
Jan 24, 2024
Reduced 99.34%
|